{"id":48016,"date":"2022-09-06T18:01:55","date_gmt":"2022-09-06T16:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/"},"modified":"2022-09-06T18:01:55","modified_gmt":"2022-09-06T16:01:55","slug":"median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/","title":{"rendered":"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\niCRO: scientific poster presentation on Sep 10, 2022: \u201cChallenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1\u201d\n<\/li>\n<li>\niBiopsy\u00ae: scientific poster presentation on Sep 11, 2022: \u201cArtificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction\u201d\n<\/li>\n<li>\nThe team will be available at Booth #447, Exhibition Hall 7.2 during the entire industry exhibition duration\n<\/li>\n<\/ul>\n<p>SOPHIA ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220906005715\/en\/1343975\/5\/Median_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220906005715\/en\/1343975\/21\/Median_RGB.jpg\"><\/a><\/p>\n<p>\nMedian Technologies (ALMDT) (Paris:ALMDT) announced today that the Company will be participating in the 2022 ESMO (European Society for Medical Oncology) Congress, to be held in Paris, France, September 9-13 (venue: Paris Expo Porte de Versailles).\n<\/p>\n<p>\nThe Company will present two scientific posters. Details of the sessions include:\n<\/p>\n<p>\n<span class=\"bwuline\"><b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcslide.ctimeetingtech.com%2Fesmo2022%2Fattendee%2Fconfcal_2%2Fpresentation%2Flist%3Fq%3D255P&amp;esheet=52858332&amp;newsitemid=20220906005715&amp;lan=en-US&amp;anchor=255P&amp;index=1&amp;md5=024c979c81a584c91b7e69a979a46533\" rel=\"nofollow noopener\" shape=\"rect\">255P<\/a><\/b><\/span><b> &#8211; Challenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1<\/b>\n<\/p>\n<p>\nSession: Breast Cancer, Metastatic<br \/>\n<br \/>Date: Sep 10, 2022<br \/>\n<br \/>Timeslot to meet the scientific team: 12:00 pm \u2013 1:00 pm CEST<br \/>\n<br \/>Place: Poster Area, Hall 4\n<\/p>\n<p>\n<span class=\"bwuline\"><b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcslide.ctimeetingtech.com%2Fesmo2022%2Fattendee%2Fconfcal_2%2Fpresentation%2Flist%3Fq%3D919P&amp;esheet=52858332&amp;newsitemid=20220906005715&amp;lan=en-US&amp;anchor=919P&amp;index=2&amp;md5=78ad925f72a13f59b6cd56205642dd1e\" rel=\"nofollow noopener\" shape=\"rect\">919P<\/a><\/b><\/span><b> &#8211; Artificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction<\/b>\n<\/p>\n<p>\nSession: New Diagnostic Tools<br \/>\n<br \/>Date: Sep 11, 2022<br \/>\n<br \/>Timeslot to meet the scientific team: 12:00 pm \u2013 1:00 pm CEST<br \/>\n<br \/>Place: Poster Area, Hall 4\n<\/p>\n<p>\nDuring the industry exhibition, Median team will be available at booth #447, Hall 7.2 to discuss the scientific posters, present the latest developments on iBiopsy\u00ae LCS CADe\/CADx SaMD as well as the Company\u2019s iCRO services for image management in oncology trials including Imaging Lab, intelligent imaging capabilities for drug development. Daily presentation sessions on Imaging Lab are planned at 3:00 pm CEST at booth.\n<\/p>\n<p>\nMore about the ESMO congress: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.esmo.org%2Fmeetings%2Fesmo-congress-2022&amp;esheet=52858332&amp;newsitemid=20220906005715&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.esmo.org%2Fmeetings%2Fesmo-congress-2022&amp;index=3&amp;md5=cee57a7541eab9bcbad86f46d3dbd7c1\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.esmo.org\/meetings\/esmo-congress-2022<\/a>\n<\/p>\n<p>\n<strong>About Median Technologies:<\/strong><b> <\/b>Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy\u00ae, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.\n<\/p>\n<p>\nFounded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label \u201cInnovative company\u201d by the BPI and is listed on Euronext Growth market (Paris). FR0011049824\u2013 ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext\u00ae PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mediantechnologies.com%2F&amp;esheet=52858332&amp;newsitemid=20220906005715&amp;lan=en-US&amp;anchor=www.mediantechnologies.com&amp;index=4&amp;md5=eeffb938952854ef598af4f8ecc398a9\" rel=\"nofollow noopener\" shape=\"rect\">www.mediantechnologies.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Median Technologies<\/b><br \/>Emmanuelle Leygues<br \/>\n<br \/>Head of Corporate Marketing &amp; Financial Communications<br \/>\n<br \/>+33 6 10 93 58 88<br \/>\n<br \/><a target=\"_blank\" href=\"mailto&#58;&#101;&#109;&#109;&#97;&#110;&#117;&#x65;&#x6c;&#x6c;&#x65;&#x2e;&#x6c;&#x65;&#x79;&#x67;&#x75;&#x65;&#x73;&#64;media&#110;&#116;&#101;&#99;&#104;&#110;&#111;&#x6c;&#x6f;&#x67;&#x69;&#x65;&#x73;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\"><span>&#x65;&#109;m&#x61;&#110;u&#x65;&#108;l&#x65;&#x2e;&#108;&#x65;&#x79;&#103;u&#x65;&#115;&#64;&#x6d;&#101;d&#x69;&#x61;&#110;&#x74;&#x65;&#99;h&#x6e;&#111;l&#x6f;&#103;i&#x65;&#115;&#46;&#x63;&#x6f;&#109;<\/span><\/a>\n<\/p>\n<p>\n<b>Press &#8211; ALIZE RP<\/b><br \/>Caroline Carmagnol<br \/>\n<br \/>+33 6 64 18 99 59<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x6d;e&#100;&#105;&#x61;&#x6e;&#64;&#97;&#x6c;&#x69;z&#101;&#x72;&#x70;&#46;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#109;&#x65;d&#x69;a&#110;&#x40;&#97;&#x6c;i&#122;&#x65;&#114;&#x70;&#46;&#x63;&#x6f;&#109;<\/a>\n<\/p>\n<p>\n<b>Investors &#8211; ACTIFIN<\/b><br \/>Ghislaine Gasparetto<br \/>\n<br \/>+33 6 21 10 49 24<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x67;&#x67;&#x61;sp&#97;&#114;&#101;&#x74;&#x74;&#x6f;&#x40;&#x61;ct&#105;&#102;&#105;&#x6e;&#x2e;&#x66;&#x72;\" rel=\"nofollow noopener\" shape=\"rect\">&#x67;&#x67;&#97;sp&#x61;&#x72;&#101;&#116;t&#x6f;&#x40;&#97;&#99;t&#x69;&#x66;&#x69;&#110;&#46;f&#x72;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>iCRO: scientific poster presentation on Sep 10, 2022: \u201cChallenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1\u201d iBiopsy\u00ae: scientific poster presentation on Sep 11, 2022: \u201cArtificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction\u201d The team will be &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48016","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"iCRO: scientific poster presentation on Sep 10, 2022: \u201cChallenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1\u201d iBiopsy\u00ae: scientific poster presentation on Sep 11, 2022: \u201cArtificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction\u201d The team will be ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-06T16:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220906005715\/en\/1343975\/21\/Median_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae\",\"datePublished\":\"2022-09-06T16:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/\"},\"wordCount\":496,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005715\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/\",\"name\":\"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005715\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"datePublished\":\"2022-09-06T16:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005715\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005715\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/","og_locale":"en_US","og_type":"article","og_title":"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae - Pharma Trend","og_description":"iCRO: scientific poster presentation on Sep 10, 2022: \u201cChallenges to Assess Bone Metastases in Blinded Independent Central Review (BICR) of Breast Cancer Trials Using RECIST 1.1\u201d iBiopsy\u00ae: scientific poster presentation on Sep 11, 2022: \u201cArtificial Intelligence Supporting Lung Cancer Screening: Computer Aided Diagnosis of Lung Lesions Driven by Morphological Feature Extraction\u201d The team will be ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-06T16:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220906005715\/en\/1343975\/21\/Median_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae","datePublished":"2022-09-06T16:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/"},"wordCount":496,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220906005715\/en\/1343975\/21\/Median_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/","url":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/","name":"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220906005715\/en\/1343975\/21\/Median_RGB.jpg","datePublished":"2022-09-06T16:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220906005715\/en\/1343975\/21\/Median_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220906005715\/en\/1343975\/21\/Median_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-participate-in-the-2022-esmo-congress-sep-9-13-2022-paris-france-with-two-scientific-posters-on-icro-and-ibiopsy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 \u2013 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48016"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48016\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}